Fidelity International
VRCA icon

Fidelity International’s Verrica Pharmaceuticals VRCA Stock Holding History

Fidelity International’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,101
Closed -$2.94M – 993
2018
Q3 		$2.94M Sell
18,101
-23,658
-57% -$4.04M ﹤0.01% 584
2018
Q2 		$8.24M Buy
+41,759
New +$8.18M 0.01% 505

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Fidelity International's VRCA Position: Q4 2018 in Review

Fidelity International sold out of Verrica Pharmaceuticals (VRCA) in Q4 2018, closing a stake of 18,101 shares — an estimated $2.94M sold.

Fidelity International first reported a position in VRCA in Q2 2018 and held it in 2 quarters. The position peaked at $8.24M in Q2 2018. 40 funds tracked by Wall St. Rank hold VRCA as of Q4 2018.

  • Fidelity International reported no remaining Verrica Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Fidelity International sold 18,101 Verrica Pharmaceuticals shares in Q4 2018, an estimated $2.94M.
  • Fidelity International first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 2 quarters.
  • Fidelity International's Verrica Pharmaceuticals position peaked at $8.24M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q4 2018.

Based on Fidelity International's 13F filing for Q4 2018, filed 13 Feb 2019.